Summary of ongoing reslizumab studies in patients with eosinophilic asthma. | Download Table
Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison - Journal of Allergy and Clinical Immunology
NICE Recommends CINQAERO (reslizumab) for the Treatment of Severe Eosinophilic Asthma » FINCHANNEL
FDA Will Review Teva's BLA for Asthma Drug Reslizumab
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
Teva files MAA for asthma treatment reslizumab
Teva's Asthma Therapy Reslizumab Fails in Late-Stage Studies
CINQAIR® (reslizumab) Injection – About Asthma Control
Reslizumab – All About Drugs
Injectable asthma drug reslizumab approved by European Commission - The Pharmaceutical Journal
Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice - CHEST
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
Reslizumab - wikidoc
Dosing and Administration
A Guide to the Prescription and Service Request Form
Reslizumab Reslizumab (Teva) | Bioz | Ratings For Life-Science Research
Reslizumab Overview - Creative Biolabs
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study - The Journal of Allergy and Clinical Immunology: In Practice
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Cinqair (reslizumab): Basics, Side Effects & Reviews
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands – An evaluation - Respiratory Medicine
Reslizumab
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials - The Lancet Respiratory Medicine
Subcutaneous Cinqair results add to Teva's troubles
